These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 22432244)
1. [New treatments of pediatric pulmonary hypertension]. Wacker J; Tissot C; Beghetti M Rev Med Suisse; 2012 Feb; 8(329):423-7. PubMed ID: 22432244 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary arterial hypertension: an update on diagnosis and treatment. Stringham R; Shah NR Am Fam Physician; 2010 Aug; 82(4):370-7. PubMed ID: 20704168 [TBL] [Abstract][Full Text] [Related]
3. Current treatment strategies for pulmonary arterial hypertension. Lee SH; Rubin LJ J Intern Med; 2005 Sep; 258(3):199-215. PubMed ID: 16115293 [TBL] [Abstract][Full Text] [Related]
5. Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs. Safdar Z Respir Med; 2011 Jun; 105(6):818-27. PubMed ID: 21273054 [TBL] [Abstract][Full Text] [Related]
6. Management of dyspnea in advanced pulmonary arterial hypertension. Sajkov D; Petrovsky N; Palange P Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377 [TBL] [Abstract][Full Text] [Related]
12. Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies. van Loon RL; Roofthooft MT; Delhaas T; van Osch-Gevers M; ten Harkel AD; Strengers JL; Backx A; Hillege HL; Berger RM Am J Cardiol; 2010 Jul; 106(1):117-24. PubMed ID: 20609658 [TBL] [Abstract][Full Text] [Related]
13. Current therapeutics and practical management strategies for pulmonary arterial hypertension. Agarwal R; Gomberg-Maitland M Am Heart J; 2011 Aug; 162(2):201-13. PubMed ID: 21835279 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension. Melnick L; Barst RJ; Rowan CA; Kerstein D; Rosenzweig EB Am J Cardiol; 2010 May; 105(10):1485-9. PubMed ID: 20451700 [TBL] [Abstract][Full Text] [Related]
16. Emerging therapies for the treatment of pulmonary hypertension. Stenmark KR; Rabinovitch M Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S85-90. PubMed ID: 20216170 [TBL] [Abstract][Full Text] [Related]
17. [Pulmonary arterial hypertension in childhood]. Douwes JM; van Loon RL; Roothooft MT; Berger RM Ned Tijdschr Geneeskd; 2011; 155(49):A3901. PubMed ID: 22166180 [TBL] [Abstract][Full Text] [Related]
18. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension. Bharani A; Mathew V; Sahu A; Lunia B Indian Heart J; 2003; 55(1):55-9. PubMed ID: 12760589 [TBL] [Abstract][Full Text] [Related]
19. Levosimendan is not effective in reducing pulmonary pressures in patients with idiopathic pulmonary arterial hypertension: report of two cases. Cavusoglu Y; Beyaztas A; Birdane A; Ata N J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):503-7. PubMed ID: 19346968 [TBL] [Abstract][Full Text] [Related]
20. Prostanoids and phosphodiesterase inhibitors in experimental pulmonary hypertension. Theo Schermuly R; Ardeschir Ghofrani H; Weissmann N Curr Top Dev Biol; 2005; 67():251-84. PubMed ID: 15949537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]